Heron Therapeutics Inc. (HRTX) announced that it has appointed Mark Hensley as Chief Operating Officer. He has more than fifteen years of experience in a variety of sales and operations positions within the pharmaceutical industry.
Before joining to Heron, Hensley held several senior leadership roles at Veloxis Pharmaceuticals, Inc., including serving as Chief Executive Officer from 2021 to 2024, and Chief Operating Officer and Chief Commercial Officer from 2018 to 2021. Earlier in his career, Mr. Hensley held positions of increasing responsibility at Cornerstone Therapeutics and Chiesi USA.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.